Eli Lilly (LLY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of ...

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and ...

Weight loss drugs are huge these days, and Eli Lilly (LLY) is leading the pack when it comes to these. However, today’s ...

Eli Lilly (LLY) reports Q4 earnings Thursday. LLY stock up 8.22% YTD. Chart shows strong bullish momentum with potential for ...

Eli Lilly and Company LLY will report its fourth-quarter and full-year 2024 earnings on Feb. 6, before market open. The Zacks ...

QXO Inc. on Monday changed tactics in its $11 billion effort to buy Beacon Roofing Supply Inc. by appealing directly to shareholders regarding its ability to use artificial intelligence in the ...

Friday – BofA Securities maintained a Buy rating on Eli Lilly stock (NYSE:LLY), with a price target set at $997.00. With a market capitalization of $706 billion and ...

Investing.com -- Eli Lilly said Wednesday that its weight-loss medication Zepbound (tirzepatide) demonstrated superior efficacy over Novo Nordisk (NYSE:NVO)'s Wegovy (semaglutide) ...

Mark Cuban Says If You Want To Get Rich, 'Throw A Hail Mary' And Invest 10% Of Savings In Bitcoin, But You Must Pretend You Already Lost It Charlie Munger Praised Buffett's $20 Billion 'No-Brainer ...

Eli Lilly & Co. (NYSE:LLY) reported much stronger-than-expected earnings for the fiscal Q2 2024 and raised its guidance for the full year. The drugmaker’s shares surged more than ...

Shares of Eli Lilly & Co. were headed for their worst day in nearly four years on Tuesday after the drugmaker provided a fourth-quarter revenue outlook that was below expectations, citing slower ...